These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 34510063)
1. Lingual Arteriovenous Malformation With Bleeding Treated With Polidocanol Foam Sclerotherapy Using Intestinal Forceps to Control Blood Flow. Sasaki Y; Sasaki S; Ishikawa K J Craniofac Surg; 2022 May; 33(3):e292-e293. PubMed ID: 34510063 [TBL] [Abstract][Full Text] [Related]
2. Auricular Arteriovenous Malformation With Macrotia Treated With Transcatheter Arterial Embolization, Polidocanol Foam Sclerotherapy and Subsequent Otoplasty Following Resection. Ishikawa K; Fujita M; Sasaki S J Craniofac Surg; 2021 Jul-Aug 01; 32(5):e489-e490. PubMed ID: 33464772 [TBL] [Abstract][Full Text] [Related]
3. Sclerotherapy for congenital vascular malformations with mixing foam of polidocanol and liquid of bleomycin. Yang WH; Xiang XJ; Li HL Phlebology; 2023 Aug; 38(7):451-457. PubMed ID: 37318342 [TBL] [Abstract][Full Text] [Related]
4. Polidocanol Sclerotherapy Combined with Transarterial Embolization Using n-Butyl Cyanoacrylate for Extracranial Arteriovenous Malformations. Kitagawa A; Yamamoto T; Matsunaga N; Yamaji M; Ikeda S; Izumi Y; Hagihara M; Ota T; Ishiguchi T Cardiovasc Intervent Radiol; 2018 Jun; 41(6):856-866. PubMed ID: 29417264 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of sclerotherapy with polidocanol foam in comparison with fluid sclerosant in the treatment of first-grade haemorrhoidal disease: a randomised, controlled, single-blind, multicentre trial. Moser KH; Mosch C; Walgenbach M; Bussen DG; Kirsch J; Joos AK; Gliem P; Sauerland S Int J Colorectal Dis; 2013 Oct; 28(10):1439-47. PubMed ID: 23775099 [TBL] [Abstract][Full Text] [Related]
7. Sclerotherapy with 3% polidocanol foam to treat second-degree haemorrhoidal disease: Three-year follow-up of a multicentre, single arm, IDEAL phase 2b trial. Gallo G; Picciariello A; Pietroletti R; Novelli E; Sturiale A; Tutino R; Laforgia R; Moggia E; Pozzo M; Roveroni M; Bianco V; Realis Luc A; Giuliani A; Diaco E; Naldini G; Trompetto M; Perinotti R; D'Andrea V; Lobascio P Colorectal Dis; 2023 Mar; 25(3):386-395. PubMed ID: 36268758 [TBL] [Abstract][Full Text] [Related]
9. Sclerotherapy: a study comparing polidocanol in foam and liquid form. Uncu H Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346 [TBL] [Abstract][Full Text] [Related]
10. Interim results of bleomycin-polidocanol foam sclerotherapy as a highly efficient technique for venous malformations. Yang X; Chen H; Gu H; Jin Y; Hu L; Hua C; Wang Y; Sun Y; Yu W; Lin X J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1066-1073. PubMed ID: 32284311 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial. Rabe E; Otto J; Schliephake D; Pannier F Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905 [TBL] [Abstract][Full Text] [Related]
12. Foam sclerotherapy for a symptomatic hepatic cyst: a preliminary report. Itou C; Koizumi J; Hashimoto T; Myojin K; Kagawa T; Mine T; Imai Y Cardiovasc Intervent Radiol; 2014 Jun; 37(3):800-4. PubMed ID: 24170168 [TBL] [Abstract][Full Text] [Related]
13. Sonographically guided percutaneous sclerosis using 1% polidocanol in the treatment of vascular malformations. Jain R; Bandhu S; Sawhney S; Mittal R J Clin Ultrasound; 2002 Sep; 30(7):416-23. PubMed ID: 12210459 [TBL] [Abstract][Full Text] [Related]
14. Endoscopic sclerotherapy with fibrin glue as compared with polidocanol to prevent early esophageal variceal rebleeding. Zimmer T; Rucktäschel F; Stölzel U; Liehr RM; Schuppan D; Stallmach A; Zeitz M; Weber E; Riecken EO J Hepatol; 1998 Feb; 28(2):292-7. PubMed ID: 9514542 [TBL] [Abstract][Full Text] [Related]
15. Sclerotherapy using 2 % polidocanol foam in the treatment of hemorrhoidal disease - a single-center experience. Figueiredo LM; Bordalo Ferreira F; Rafael MA; Oliveira AM Rev Esp Enferm Dig; 2022 Mar; 114(3):185-186. PubMed ID: 34517712 [TBL] [Abstract][Full Text] [Related]
16. Foam Polidocanol Sclerotherapy for Low-Flow Vascular Malformations of Tongue. Mukul SK; Singh A; Kumar A; Pandey S; Singh S; Kumar A Ann Maxillofac Surg; 2019; 9(2):257-260. PubMed ID: 31909004 [TBL] [Abstract][Full Text] [Related]
17. Percutaneous sclerotherapy with polidocanol under the guidance of ultrasound for venous malformations in children - A retrospective cohort study from a single tertiary medical center. Hou F; Chen J; Xia M; Ding K; Zeng Q; Liu W Medicine (Baltimore); 2020 Feb; 99(9):e18839. PubMed ID: 32118707 [TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of foam sclerotherapy for treatment of low-flow vascular malformations in children. Markovic JN; Nag U; Shortell CK J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1074-1082. PubMed ID: 32284312 [TBL] [Abstract][Full Text] [Related]
19. Treatment of low-flow vascular malformations by ultrasound-guided sclerotherapy with polidocanol foam: 24 cases and literature review. Blaise S; Charavin-Cocuzza M; Riom H; Brix M; Seinturier C; Diamand JM; Gachet G; Carpentier PH Eur J Vasc Endovasc Surg; 2011 Mar; 41(3):412-7. PubMed ID: 21111641 [TBL] [Abstract][Full Text] [Related]
20. High-flow arteriovenous malformation of the lower extremity: ethanolamine oleate sclerotherapy. Hyodoh H; Fujita A; Hyodoh K; Furuse M; Kamisawa O; Hareyama M Cardiovasc Intervent Radiol; 2001; 24(5):348-51. PubMed ID: 11815844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]